IBDEI0TZ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14799,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,14799,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,14800,0)
 ;;=490.^^90^868^16
 ;;^UTILITY(U,$J,358.3,14800,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14800,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,14800,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,14800,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,14801,0)
 ;;=682.8^^90^868^19
 ;;^UTILITY(U,$J,358.3,14801,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14801,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,14801,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,14801,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,14802,0)
 ;;=585.9^^90^868^20
 ;;^UTILITY(U,$J,358.3,14802,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14802,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,14802,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,14802,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,14803,0)
 ;;=428.0^^90^868^17
 ;;^UTILITY(U,$J,358.3,14803,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14803,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,14803,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,14803,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,14804,0)
 ;;=496.^^90^868^18
 ;;^UTILITY(U,$J,358.3,14804,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14804,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,14804,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,14804,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,14805,0)
 ;;=414.01^^90^868^21
 ;;^UTILITY(U,$J,358.3,14805,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14805,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,14805,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,14805,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,14806,0)
 ;;=311.^^90^868^22
 ;;^UTILITY(U,$J,358.3,14806,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14806,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,14806,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,14806,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,14807,0)
 ;;=250.01^^90^868^23
 ;;^UTILITY(U,$J,358.3,14807,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14807,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,14807,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,14807,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,14808,0)
 ;;=250.00^^90^868^24
 ;;^UTILITY(U,$J,358.3,14808,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14808,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,14808,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,14808,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,14809,0)
 ;;=305.90^^90^868^26
 ;;^UTILITY(U,$J,358.3,14809,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14809,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,14809,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,14809,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,14810,0)
 ;;=305.93^^90^868^25
 ;;^UTILITY(U,$J,358.3,14810,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14810,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,14810,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,14810,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,14811,0)
 ;;=796.2^^90^868^28
 ;;^UTILITY(U,$J,358.3,14811,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14811,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,14811,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,14811,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,14812,0)
 ;;=607.84^^90^868^29
 ;;^UTILITY(U,$J,358.3,14812,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14812,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,14812,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,14812,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,14813,0)
 ;;=530.81^^90^868^30
 ;;^UTILITY(U,$J,358.3,14813,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14813,1,4,0)
 ;;=4^530.81
